CC
LLY icon

Centiva Capital’s Eli Lilly LLY Stock Holding History

Centiva Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2M Sell
41,000
-34,000
-45% -$34.7M 0.43% 48
2026
Q1 		$69M Sell
75,000
-61,300
-45% -$62.1M 0.51% 37
2025
Q4 		$146M Sell
136,300
-51,000
-27% -$48.8M 1.19% 12
2025
Q3 		$143M Buy
+187,300
New +$139M 1.36% 16
2024
Q4 		– Sell
-1,600
Closed -$1.42M – 2080
2024
Q3 		$1.42M Buy
1,600
+300
+23% +$270K 0.03% 642
2024
Q2 		$1.18M Sell
1,300
-3,700
-74% -$2.96M 0.02% 691
2024
Q1 		$3.89M Buy
5,000
+2,000
+67% +$1.42M 0.1% 159
2023
Q4 		$1.75M Sell
3,000
-9,100
-75% -$5.31M 0.04% 401
2023
Q3 		$6.5M Buy
12,100
+5,000
+70% +$2.58M 0.14% 123
2023
Q2 		$3.33M Sell
7,100
-6,000
-46% -$2.52M 0.07% 266
2023
Q1 		$4.5M Buy
13,100
+9,100
+228% +$3.07M 0.11% 200
2022
Q4 		$1.46M Sell
4,000
-7,600
-66% -$2.69M 0.04% 446
2022
Q3 		$3.75M Buy
11,600
+1,600
+16% +$507K 0.07% 209
2022
Q2 		$3.24M Buy
10,000
+3,000
+43% +$901K 0.08% 232
2022
Q1 		$2M Sell
7,000
-91,000
-93% -$23.4M 0.04% 433
2021
Q4 		$27.1M Buy
+98,000
New +$24.8M 0.56% 31
2020
Q3 		– Sell
-2,600
Closed -$427K – 799
2020
Q2 		$427K Sell
2,600
-84,300
-97% -$12.9M 0.03% 326
2020
Q1 		$12M Buy
86,900
+54,700
+170% +$7.52M 0.54% 17
2019
Q4 		$4.23M Buy
+32,200
New +$3.73M 0.21% 102
2019
Q2 		– Sell
-21,300
Closed -$2.76M – 477
2019
Q1 		$2.76M Sell
21,300
-78,400
-79% -$9.53M 0.19% 89
2018
Q4 		$11.5M Buy
99,700
+96,700
+3,223% +$10.8M 0.91% 19
2018
Q3 		$322K Sell
3,000
-19,400
-87% -$1.94M 0.03% 148
2018
Q2 		$1.91M Buy
+22,400
New +$1.84M 0.41% 25

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's LLY Position: Q2 2026 in Review

Centiva Capital reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $3.02M and leaving 7,922 shares worth $9.5M. The position accounts for 0.08% of the portfolio, ranked #177.

Centiva Capital first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $29.7M in Q3 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centiva Capital held 7,922 shares of Eli Lilly worth $9.5M as of Q2 2026.
  • Centiva Capital sold 2,955 Eli Lilly shares in Q2 2026, an estimated $3.02M.
  • Eli Lilly made up 0.08% of Centiva Capital's portfolio in Q2 2026, its #177 holding.
  • Centiva Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • Centiva Capital's Eli Lilly position peaked at $29.7M in Q3 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.